An upstart biopharma firm founded by two former executives at CinCor Pharma – which celebrated a $1.8B exit to AstraZeneca in ...

We recently published a list of 10 AI News And Ratings on Wall Street’s Radar. In this article, we are going to take a look ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 13.37%, which has investors questioning if this is right time to sell.

Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

The London-listed pharma company said Thursday that the new deadline for Hookipa to either make an offer for the company or walk away has been extended to Feb. 27. It was previously set for 1700 GMT ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

AI-related deals in the pharmaceutical sector grew by 14% compared to the same period in 2023. This year, AI is expected to ...

Theravance Biopharma Inc . (NASDAQ:TBPH) stock reached a 52-week high this week, touching $10.47 amid a fluctuating market.

Sara Klein was promoted to chief legal officer at Alumis, a clinical stage biopharmaceutical company, according to a Tuesday announcement.

Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.